Hospital Israelita Albert Einstein
Clinical trials sponsored by Hospital Israelita Albert Einstein, explained in plain language.
-
Texts vs. calls: can simple reminders ease crowded emergency rooms?
Disease control Not yet recruitingThis study aims to reduce emergency room crowding by improving how patients connect with doctors after leaving. It will test if sending text and email reminders helps discharged patients contact a telemedicine team faster to discuss their lab results. The goal is to see if this n…
Phase: NA • Sponsor: Hospital Israelita Albert Einstein • Aim: Disease control
Last updated Apr 04, 2026 05:20 UTC
-
New hope for sickle cell cure: High-Dose drug trial aims to unlock gene therapy
Disease control Not yet recruitingThis study is testing if a high dose of a drug called plerixafor can safely and effectively collect enough stem cells from people with sickle cell disease. These collected cells are a necessary first step for future gene therapy treatments, which aim to correct the disease at its…
Phase: PHASE1, PHASE2 • Sponsor: Hospital Israelita Albert Einstein • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Brazil launches major study to follow sepsis survivors for one year
Knowledge-focused Not yet recruitingThis study aims to better understand what happens to sepsis patients after they leave the hospital. Researchers will follow 760 adult patients in Brazil for one year after their hospital stay to track their recovery, quality of life, and any complications. This is an observationa…
Sponsor: Hospital Israelita Albert Einstein • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:41 UTC